Oculis Holding AG (OCS) Treasury Shares (2021 - 2026)
Oculis Holding AG (OCS) posted quarterly Treasury Shares of -$21709.1 for Q1 2026, up 44.23% year-over-year from -$15051.3 in Q1 2025, and down 147.87% quarter-over-quarter from -$8758.2 in Q4 2025.
Oculis Holding AG (OCS) Treasury Shares (2021 - 2026) Analysis & Trends
Oculis Holding AG's Treasury Shares history runs 5 years deep, the most recent figure standing at -$21709.1 for Q1 2026.
- In Q1 2026, Treasury Shares rose 44.23% year-over-year to -$21709.1; the TTM figure through Mar 2026 stood at -$21709.1 (up 44.23% YoY), while the FY2025 annual figure was -$8442.9, up 25.72% from the prior year.
- Treasury Shares for Q1 2026 stood at -$21709.1, down from -$8758.2 in the prior quarter.
- The five-year high for Treasury Shares was -$1038.0 in Q4 2022, with the low at -$43753.8 in Q3 2025.
- The 4-year median for Treasury Shares is -$11542.1 (2024), against an average of -$21164.4.
- The sharpest annual moves came in 2025 and 2026: Treasury Shares slumped 282.32% in 2025, then jumped 44.23% in 2026.
- Oculis Holding AG's Treasury Shares stood at -$1038.0 in 2022, then slumped by 999.71% to -$11415.2 in 2024, then gained by 23.28% to -$8758.2 in 2025, then tumbled by 147.87% to -$21709.1 in 2026.
- Business Quant data shows OCS's Treasury Shares at -$21709.1 in Q1 2026, -$8758.2 in Q4 2025, and -$43753.8 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Oculis Holding AG | 879.09 Mn | 590.21 Mn | - | 78,444.82 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 78,444.82 |
| Jun 30, 2026 | 78,444.82 |
| Mar 31, 2026 | -21,709.08 |
| Mar 31, 2026 | -21,709.08 |
| Dec 31, 2025 | -8,758.19 |
| Dec 31, 2025 | -8,758.19 |
| Sep 30, 2025 | -43,753.83 |
| Sep 30, 2025 | -43,753.83 |
| Jun 30, 2025 | -42,276.16 |
| Jun 30, 2025 | -42,276.16 |
| Mar 31, 2025 | -38,928.77 |
| Mar 31, 2025 | -38,928.77 |
| Dec 31, 2024 | -11,415.22 |
| Dec 31, 2024 | -11,415.22 |
| Sep 30, 2024 | -11,542.07 |
| Sep 30, 2024 | -11,542.07 |
| Jun 30, 2024 | -11,057.93 |
| Jun 30, 2024 | -11,057.93 |
| Dec 31, 2022 | -1,038.02 |
| Dec 31, 2022 | -1,038.02 |